|
SE367181B
(enExample)
*
|
1969-05-14 |
1974-05-20 |
Takeda Chemical Industries Ltd |
|
|
US3644479A
(en)
*
|
1970-02-09 |
1972-02-22 |
Bristol Myers Co |
1-indancarboxylic acids and derivatives
|
|
US3663627A
(en)
*
|
1970-06-01 |
1972-05-16 |
Bristol Myers Co |
1-indanmethanols
|
|
CH585687A5
(enExample)
*
|
1972-08-24 |
1977-03-15 |
Ciba Geigy Ag |
|
|
NO743135L
(enExample)
*
|
1973-09-11 |
1975-04-07 |
Sandoz Ag |
|
|
FR2359135A1
(fr)
*
|
1976-07-22 |
1978-02-17 |
Hexachimie |
Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique
|
|
JPS6055071B2
(ja)
*
|
1982-04-16 |
1985-12-03 |
四国化成工業株式会社 |
イミダゾリル琥珀酸化合物および該化合物を用いるエポキシ樹脂硬化方法
|
|
JPS60105645A
(ja)
*
|
1983-11-12 |
1985-06-11 |
Yasumitsu Tamura |
アリ−ルコハク酸エステルの製造法
|
|
US4933398A
(en)
*
|
1987-07-01 |
1990-06-12 |
Ciba-Geigy Corporation |
Photosensitive epoxy resins and use thereof
|
|
DD271903A1
(de)
*
|
1988-05-17 |
1989-09-20 |
Univ Halle Wittenberg |
Verfahren zur herstellung stabiler, 2-unsubstituierter imidazol-3-oxide
|
|
AU6024998A
(en)
*
|
1997-01-15 |
1998-08-07 |
Glycomed Incorporated |
Aryl c-glycoside compounds and sulfated esters thereof
|
|
ZA98376B
(en)
*
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
|
US5804581A
(en)
*
|
1997-05-15 |
1998-09-08 |
Bayer Corporation |
Inhibition of matrix metalloproteases by substituted phenalkyl compounds
|
|
US6130220A
(en)
*
|
1997-10-16 |
2000-10-10 |
Syntex (Usa) Inc. |
Sulfamide-metalloprotease inhibitors
|
|
US20010014688A1
(en)
*
|
1997-11-14 |
2001-08-16 |
Thomas E. Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
US20010039287A1
(en)
*
|
1997-11-14 |
2001-11-08 |
Thomas E Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
EP1042270B1
(en)
*
|
1997-12-17 |
2003-04-09 |
Chirotech Technology Limited |
Asymmetric hydrogenation
|
|
DE69917124T2
(de)
*
|
1998-04-10 |
2005-05-12 |
Pfizer Products Inc., Groton |
Cyclobutyl-Aryloxysulfonylamin-Hydroxamsäurederivate
|
|
PA8469501A1
(es)
*
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
UA71586C2
(en)
*
|
1998-12-04 |
2004-12-15 |
Smithkline Beecham Corp |
A vitronectin receptor antagonist
|
|
AU775701B2
(en)
*
|
1999-02-08 |
2004-08-12 |
G.D. Searle & Co. |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
WO2000055134A1
(en)
*
|
1999-03-18 |
2000-09-21 |
Celgene Corporation |
Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
|
|
JP2000271485A
(ja)
*
|
1999-03-24 |
2000-10-03 |
Kazuhiko Saigo |
オレフィン類のビスアルコキシカルボニル化触媒、及びコハク酸エステル誘導体の製造法
|
|
EP1165500A1
(en)
*
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
|
|
BR0011539A
(pt)
*
|
1999-05-28 |
2002-02-26 |
Pfizer Prod Inc |
Hidroxamidas de ácido 3-(arilsulfonilamino)-tetrahidropirano-3-carboxìlico
|
|
HN2000000052A
(es)
*
|
1999-05-28 |
2001-02-02 |
Pfizer Prod Inc |
Hidroxiamidas de acidos 3- (arilsulfonilamino)- tetrahidrofuran-3-carboxilicos.
|
|
US6387901B1
(en)
*
|
1999-07-06 |
2002-05-14 |
Pfizer Inc |
Alkyne containing metalloproteinase inhibitors
|
|
GB9916562D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Pharmacia & Upjohn Spa |
3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora
|
|
US20010049449A1
(en)
*
|
1999-12-23 |
2001-12-06 |
Becker Daniel P. |
Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as MMP inhibitors
|
|
US6458822B2
(en)
*
|
2000-03-13 |
2002-10-01 |
Pfizer Inc. |
2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
|
|
WO2003006670A2
(en)
*
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
BR0314898A
(pt)
*
|
2002-11-19 |
2005-08-02 |
Galderma Res & Dev |
Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
|
|
EP1737809B1
(en)
*
|
2004-02-27 |
2013-09-18 |
Amgen, Inc |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
|